Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | HTR2B | P41595 | 2/20 | 0.46 |
| ▸ | HTR7 | P34969 | 1/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | CDC25A | P30304 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | CD69 | Q07108 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8012168 | 0.84 | RAB9A (0.59) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL1156914 | 0.80 | NPC1 (0.74) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL7598451 | 0.78 | ALDH1A1 (0.39) | RAB9ANPC1PARP1KDM4EALDH1A1 | |
| SCHEMBL15671164 | 0.78 | RAB9A (0.51) | RAB9ANPC1PNMTKDM4EALDH1A1 | |
| SCHEMBL8523597 | 0.78 | NPC1 (0.58) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL29171790 | 0.78 | NPC1 (0.54) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL14037316 | 0.77 | DRD2 (0.57) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL1567603 | 0.76 | RAB9A (0.74) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL15546984 | 0.76 | NPC1 (0.53) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL15546982 | 0.76 | NPC1 (0.53) | RAB9ANPC1HTR2BHTR7PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9938321-B2 | Cyclic peptoid oligomers, pharmaceutical compositions and methods of using the same | NEW YORK UNIVERSITY (US) | 2018-04-10 | — | — | US | disclosed |
| WO-2014159937-A1 | CYCLIC PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | NEW YORK UNIVERSITY (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140274916-A1 | CYCLIC PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | NATIONAL SCIENCE FOUNDATION | 2014-09-18 | — | — | US | disclosed |
| EP-0741743-B1 | CYCLIC NEUROKININ A ANTAGONISTS | MERRELL PHARMA INC (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0741743-A1 | CYCLIC NEUROKININ A ANTAGONISTS | MERRELL PHARMACEUTICALS INC. (US) | 1996-11-13 | — | — | EP | disclosed |
| US-5521156-A | HEXAPEPTIDES AND OCTAPEPTIDES | MERRELL PHARMACEUTICALS INC. (US) | 1996-05-28 | — | — | US | disclosed |
| WO-1995021187-A1 | CYCLIC NEUROKININ A ANTAGONISTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-08-10 | — | — | WO | disclosed |
| EP-0528172-A1 | (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists | J. URIACH & CIA. S.A. (ES) | 1993-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140274916-A1 | CYCLIC PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME | NGLY1, FPR1, REV1 | RAB9A 3235/4885NPC1 315/4885HTR2B 3404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.